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Modeling Menstrual Cycle Length and
Variability at the Approach of Menopause
Using Bayesian Changepoint Models
Xiaobi Huang, Michael R. Elliott, and Sioban D. Harlow
Abstract
As women approach menopause, the patterns of their menstruation cycle lengths
change. To study these changes, we need to jointly model both the mean and vari-
ability of the cycle length. The model incorporates separate mean and variance
change points for each woman and a hierarchical model to link them together,
along with regression components to include predictors of menopausal onset such
as age at menarche and parity. Data are from TREMIN, an ongoing 70-year old
longitudinal study that has obtained menstrual calendar data of women throughout
their reproductive life course. An additional complexity arises from the fact that
these calendars have substantial missingness due to hormone use, surgery, fail-
ure to report, and loss of contact. We integrate multiple imputation and time-to
event modeling in our Bayesian estimation procedure to deal with different forms
of the missingness. Posterior predictive model checks are applied to evaluate the
model fit. Our method successfully modeled patterns of women’s menstrual cy-
cle trajectories throughout their late reproductive life and identified the change
points for mean and variability of segment length, which provides insight into the
menopausal process. More generally, our model points the way toward increasing
use of joint mean-variance models to predict health outcomes and better under-
stand disease processes.
1 Introduction
Menstrual cycles are the most easily observed markers of ovarian function throughout re-
productive life. Changes in menstrual bleeding patterns are important indicators of ovarian
aging, endocrine disruption and endocrine risk factors for chronic disease (Harlow 1995).
The menopausal transition is increasingly recognized to be a critical period in women’s lives
as physiologic changes and health practices adopted during this period frequently define
women’s long term chronic disease risk profile (Wildman et al. 2008, Sowers et al. 2006,
Avis et al. 2004). Given this recent interest in the interface between reproductive and so-
matic aging, several proposals for staging reproductive aging have emerged. The Stages of
Reproductive Aging Workshop (STRAW) recommendations (Soules et al. 2001), its mod-
ifications (Harlow et al. 2007) and several other proposals (Mitchell et al. 2000,Taffe and
Dennerstein 2002, Mansfield et al. 2004) define criteria primarily by menstrual bleeding char-
acteristics to determine onset of the transition, as well as the stages within the transition
period.
Information on the patterns of menstrual bleeding across the reproductive lifespan derives
mainly from four seminal menstrual calendar studies, including three studies from Caucasian
populations (Chiazze et al. 1968, Treloar et al. 1967, Vollman 1977) and one study from
a Japanese population (Matsumoto et al. 1962, Matsumoto et al. 1979). Treloar (1981)
was the first to estimate age at entry into the menopausal transition by visual inspection of
menstrual cycle lengths for the 12 year period prior to the final menstrual period (FMP). He
observed that during the menopausal transition longer intervals become mixed with shorter
than usual intervals, increasing the variability in cycle length. He defined onset of the
menopausal transition as the age at which variability in cycle length visually increased, and
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estimated median age of entry into the transition at 45.5 years with a median duration of
transition of 4.8 years. Brambilla et al. (1994) introduced the term “late perimenopause”
and defined women as being in the late stage of the transition by self-report of 3-9 months of
amenorrhea or menstrual irregularity. Subsequently, investigators from several longitudinal
studies (Melbourne Women’s Midlife Health Project [MWMHP] (Dennerstein et al. 1993),
Seattle Midlife Women’s Health Study [SWMHS] (Mitchell et al. 2000), TREMIN (Treloar
et al. 1967)) proposed various bleeding criteria to define the transition period (Taffe and
Dennestein 2002, Mitchell et al. 2000, Mansfield et al. 2004, Lisabeth et al. 2004a).
STRAW defined stages principally by changes in menstrual bleeding characteristics and,
to a lesser extent, by changes in serum follicle-stimulating hormone (FSH) levels (Soules
et al. 2001). STRAW divided reproductive life prior to menopause into the reproductive
years (3 stages) and the transition years (2 stages, early and late transition). Entry into
the early transition is characterized by increased variability in menstrual cycle length while
entry into the late transition is characterized by the occurrence of skipped cycles or amen-
orrhea. The STRAW recommendations by (Soules et al. 2001), although based on emerging
results of the large cohort studies of midlife women, were not data-driven. The multi-study
ReSTAGE Collaboration subsequently evaluated bleeding criteria that served as the basis
of the STRAW recommendations and documented the extent to which the various proposed
criteria identified a similar moment in women’s reproductive life (Harlow et al. 2006, Harlow
et al. 2007, Harlow et al. 2008). Essentially, all of these proposals attempt to define bleeding
criteria that identify a change-point in women’s menstrual cycle histories. Notably, however,
none of the papers attempted to model these changepoints longitudinally.
Harlow et al. (2000) longitudinally modeled change in mean cycle length, as well as
in between-woman and within-woman variance across the reproductive lifespan and found
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that within-woman heterogeneity in cycle length was an important source of variation in
menstrual patterns, especially after age 40. They fitted a bipartite cubic spline model that
modeled the risk of both very short and very long segments using changepoints fixed at ages
34 and 40. Lisabeth et al. (2004b) used generalized estimating equations to model changes
in mean cycle length and variance independent of the mean referenced to age at FMP and
demonstrated that variance in menstrual cycle lengths increase on average 2 to 6 years before
increases in the mean, depending on age at FMP.
Prior descriptive analyses also suggest that there is some heterogeneity in women’s men-
strual trajectories. Menstrual characteristics in young adult women are associated with
fertility (Small et al. 2006) and the timing of menopause (Den Tonkelaar et al. 1998, Wal-
lace et al. 1979, Lisabeth et al. 2004b). A prior analysis of the TREMIN data by (Wallace
et al. 1979) reported that women with later menopause had longer mean cycle length and
greater variability two years before menopause than women with earlier menopause. Lisa-
beth and colleagues (Lisabeth et al. 2004b) in a longitudinal analysis of the same data also
reported that longer cycles were associated with a later age of menopause. Another study
(Den Tonkelaar et al. 1998) reported that women with a late age at menopause (55-59)
had a longer mean cycle length in the nine years prior to menopause than women with an
earlier menopause. Weinstein and colleagues (Weinstein et al. 2003) found that low serial
irregularity, a measure of the variability of the changes in cycle length, was associated with
younger age at FMP, after adjusting for age at menarche, number of births, and hormone
use.
Our goal is to model how menstrual cycle length and variability change when women
approach menopause. We assume that there are underlying unknown mean and variance
changepoints for each individual woman and build a Bayesian change point model to estimate
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distributions of these changepoints. Furthermore, we impute cycles that are missing due
to hormone use, gaps in the menstrual calendar and gynecological surgery, allowing more
subjects and information to be included. Most prior reports have censored women when
they began using hormonal contraceptives or hormone therapy (HT) (Weinstein et al. 2003,
Guo et al. 2006, Harlow et al. 2006, Harlow et al. 2008).
Statistically, the objective is to model both the mean and variance of a set of curves.
Several approaches have been proposed for correlated functional data of this type, includ-
ing the bipartite spline model proposed by (Harlow et al. 2000) which modelled mean and
between-subject variance by a linear random effect model and used a two-stage log-linear
regression to study within-subject variance vs. age. Crainiceanu et al. (2007) proposed
Bayesian penalized splines to model both mean and variance by using a set of fixed knots for
the splines with structural covariance matrix and random effects to depict the heterogeneity
of variance. Lisabeth et al. (2004b) modeled means and variances over time separately
using independent generalized estimating equations. Gunn and Dunson (2005) modeled hor-
mone patterns in the menstrual cycles using a Bayesian hierarchical model and mapped the
posterior draws to a constrained space which guarantees that each curve increases mono-
tonically to an unknown changepoint and decreases afterwards. To model student test
achievement, Thum and Bhattacharya (2001) proposed a hierarchical Bayesian regression
model which included two-phase composite of yi ∼ N(β01 + β11xi, σ21), i = 1, 2, . . . , k and
yi ∼ N(β02 + β12xi, σ22), i = k + 1, k + 2, . . . , n where k was the unknown change point.
Hall et al. (2003) used unknown change points for the splines to capture individual cognitive
function over time. These approaches estimated unknown changepoints for the mean but did
not model the variance function over time. Davidian and Carroll (1987) proposed another
approach for variance function estimation, which models the variance as proportional to a
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power of the mean response. This approach builds a separate function to model variance but
did not include changepoints. Here we consider a Bayesian hierarchical model that estimates
individual-level mean and variance profiles with unknown changepoints. These changepoints
represent measures of menopausal transition, and, together with intercepts and pre- and
post-changepoint slopes, provide detailed summaries of the menstrual cycle data that can
be related to individual level covariates such as age at menarche, parity, and secular cohort
membership.
Our article is organized as follows. In section 2 we describe the TREMIN study data. In
section 3 we describe a Bayesian model to study the trajectories of women’s menstrual cycle
length that estimates unknown changepoints for both means and variances and allows these
changepoints to be functions of subject-level covariates. In addition, we impute different
forms of missingness in the data set and incorporate the imputation in the Markov Chain
Monte Carlo sampling used to estimate the algorithm. In section 4 we give the results from
fitted the model to menstrual data, along with Bayesian posterior predictive model checks.
In section 5 we discuss how our results compare to and extend previous menstrual cycle
staging research, along with possible extensions of our model.
2 The TREMIN Dataset
Our models are designed for the TREMIN data, one of the only two data sets available
providing individual women’s menstrual calendar data across their reproductive life span.
The study, initiated by Dr. Alan Treloar (Treloar et al. 1967), recruited the first cohort
of TREMIN: 2350 college-aged women attending the University of Minnesota between 1934
and 1939.
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Definitions recommended by WHO (Belsey and Farley 1987) were used to summarize the
calendar data. A bleeding segment, analogous to the term menstrual cycle, is a period of
consecutive bleeding days and the subsequent bleeding-free days. Bleed-free intervals had to
consist of at least 3 days; 1-2 bleed-free days between 2 bleeding days were considered part of
the bleeding episode. Bleeding segment length is the dependent variable in our study. Age at
menopause is determined by the date of final menstrual period (FMP), which is attributed
retrospectively after 12 months of amenorrhea on the calendar cards (WHO 1996).
We used data from 617 women in the 1935-1939 cohort who were a) age 25 or less at en-
rollment, b) used hormones for less than four years continuously, c) had at least one observed
segment before age 40, and d) were not censored before age 40 (Data tape TRUST998.FINAL,
March 1993). We consider segment lengths beginning at age 35. After this left truncation,
the data set has a total of 95,246 observed menstrual segment records. Each record consists
of woman’s age, bleeding segment length, and status indicators for pregnancy, hormone use
and surgery. Related subject-level information including age at menarche and parity are also
available.
Pregnancy intervals as well as the first two segments after a birth and the first seg-
ment after a spontaneous abortion are coded as non-menstrual intervals. Many women used
exogenous hormones at some point during their reproductive lives, mainly as hormonal re-
placement therapy. When hormones are used, the bleeding segment is coded as a treated
interval, during which ovarian function is masked. Thus, the segment data are considered
to be missing when women use hormones. A one-segment washout period after hormone use
ended was also treated as missing. Many studies of menstrual characteristics censor women
when they begin hormone use or ignore the time period during which women are using hor-
mones. However, Wegienka and Baird (2003) suggested that these strategies may introduce
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bias since hormone users are not a random sample of menstruating women. Omitting these
women or portions of their data will provide an incomplete description of experiences in
the overall population. In our analysis, we consider these data as missing and impute their
values for hormone use gaps of up to four years. Studies have not found that hormonal use
influences menstrual segment length after stopping use and allowing for a washout period
(Taylor et al. 1977, Treloar and Behn 1971).
The 617 women included in our analysis each contributed between 15 and 321 non-
missing segments to the analysis. The observed segment lengths vary from 4 to 366 days
with a median of 27 days. Final menstruation periods (FMPs) were observed for 313 subjects
(50.7%). Only 105 (17.0%) have complete data.
Figure 1 displays log segment lengths for four typical women in the TREMIN data set.
Subject A has complete data. She has a pregnancy gap which is not included in the analysis,
no gynecological surgery or periods of hormone use, and has an observed final menstruation
period (FMP). Subject B was coded as using hormones from age 36.07 to age 37.24, and her
information for this period is treated as missing. Her FMP is observed, however. Subject
C has intermittent missingness at age 36.95. She had a hysterectomy at age 45.78, thus her
menstrual history was truncated at this point and no FMP was observed. Subject D has
intermittent missing at age 39.59 and from age 41.56 to 43.64. She began hormone therapy
after age 50.21, with no untreated bleeds recorded afterwards; thus no FMP was observed.
3 Modeling Menstrual Cycle Data
We construct a Bayesian change point model for the mean and variance of the segment
length.
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3.1 Change Point Model for Mean and Variance
Let yit denote the t
th menstrual segment length of subject i. Let ait denote the age at
the beginning of the tth menstrual segment of subject i, where i = 1, . . . , N , t = 1, . . . , Ti,
N = 617.
We consider a log-normal model with a linear change point for both the mean and variance
for each subject:
log(yit)|µit, σ2it ∼ N(µit, σ2it)
µit = α
µ
i + β
µ
i (ait − 35) + γµi (ait − θµi )+
log(σ2it) = α
σ
i + β
σ
i (ait − 35) + γσi (ait − θσi )+
The function (x)+ = x if x ≥ 0, (x)+ = 0 if x < 0; θµi and θσi are the unknown change
points of mean and variance for subject i. The change points create a linear spline for each
mean and variance model. We denote these eight subject-level parameters for each woman
as Φi = (α
µ
i , β
µ
i , γ
µ
i , θ
µ
i , α
σ
i , β
σ
i , γ
σ
i , θ
σ
i )
′.
To link the subject-level models, we postulate a multivariate normal prior for the subject-
level parameters:
Φi
ind∼ N(x′iΛ,Ω)
where xi are covariates associated with subject i. Thus Λ and Ω can also be considered as
population level parameters, with Λ as the regression coefficients and Ω⊗IN as the covariance
matrix for the regression of Φi on xi.
We complete the model specification by postulating an Inverse-Wishart hyperprior for Λ
and Ω:
p(Λ,Ω) = Inv −Wishart(Ω; 1, I)
which is completely flat for Λ and weakly informative for Ω.
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3.2 Posterior Inference
Let zit = log(yit). The goal of our analysis is to obtain inference on the joint posterior
distribution of Φ, Λ, and Ω conditional on the observed data zobs. The posterior based on
the complete data z is given by
p(Φ,Λ,Ω|z) ∝
N∏
i=1
[
Ti∏
t=1
p(zit|Φi)p(Φi|Λ,Ω)]p(Λ,Ω) ∝
[
N∏
i=1
[
Ti∏
t=1
1
σit
exp(−(zit − µit)
2
2σ2it
)]|Ω|− 12 exp(−1
2
(Φi−x′iΛ)′Ω−1(Φi−x′iΛ))]|Ω|−
k+2
2 exp(−1
2
tr(Ω−1)) =
[
N∏
i=1
Ti∏
t=1
σ−1it
]
| Ω |−N+k+22 exp
{
N∑
i=1
[
Ti∑
t=1
(zit − µit)2
σ2it
+ (Φi − x′i)′Ω−1(Φi − x′i)
]
+ tr(Ω−1)
}
where µit = α
µ
i + β
µ
i (ait − 35) + γµi (ait − θµi )+, σ2it = exp(ασi + βσi (ait − 35) + γσi (ait − θσi )+),
k = dim(Ω) = 8. We sample the parameters via a MCMC algorithm that uses Metropolis-
within-Gibbs sampling. Details of the procedure is in Appendix A.
Missing data are imputed under a missing at random (MAR) assumption (Little and
Rubin 2002) using a standard selection model. Imputation is embedded within the MCMC
algorithm. Details are provided in the next section.
3.3 Imputation of Missing Data
The majority (512 of the 617 women) have some form of missing data. For 313 women, their
segment lengths are censored due to dropout while still menstruating, surgical termination
of menstruation due to hysterectomy or bilateral oophorectomy, or hormone use that began
before FMP and continued past FMP. For the remaining 207 women, missingness was only
intermittent. Intermittent missingness occurred due to sporadic non-reporting (women fail-
ing to report an individual segment or series of segments), or to periodic hormone use that
stopped before one of the censoring events.
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There is concern that missingness, particularly missingness due to hormone use, is not
missing completely at random. In order to deal with the different types of missingness, we
impute the missing data under a missing at random (MAR) assumption. To ensure that the
imputation is proper (i.e., fully conditions on the observed data), we need to ensure that
the imputed segment lengths sum to the length of the gap between observed segments. In
addition, when censoring is present, we need to estimate the age of the FMP in order to
terminate the imputation process.
When missingness is intermittent, we ensure that the imputed missing segment lengths
sum to the length of the gap using an importance sampling algorithm. For notational
simplicity, we assume that we have a single missing gap of length Li for subject i, starting
after segment yik. Conditional on Φi, the unobserved segment lengths (yi,k+1, ..., yi,k+S)
′ = y˜i
in the gap are independent, subject to the constraint that
∑S
s=1 yi,k+s = T . We obtain a
draw log(yrepi,k+1) ∼ N(µi,k+1, σ2i,k+1) where µi,k+1 = αµi + βµi (ai,k+1 − 35)+ + γµi (ai,k+1 − θµi )+
and σ2i,k+1 = exp(α
σ
i +β
σ
i (ai,k+1− 35)++ γσi (ai,k+1− θσi )+) and ai,k+1 = aik+ yik is the age of
the start of segment yrepi,k+1. A draw of y
rep
i,k+2 is then obtained as for y
rep
i,k+1, where now ai,k+2 =
ai,k+1+y
rep
i,k+1. This process is repeated until we obtain y
rep
i,k+S such that
∑S
s=1 y
rep
i,k+s > Li. We
then replace yrepi,k+S with y˜
rep
i,k+S = Li−
∑S−1
s=1 y
rep
i,k+s. Let (y
(t)
i,k+1, ..., y
(t)
i,k+S−1, y˜
(t)
i,k+S) = y˜
(t)
i be the
tth vector of imputations, t = 1, ..., 50. Finally, we draw one of the 50 sets with probability
pt =
f(y˜
(t)
i |Φi)P
t f(y˜
(t)
i |Φi)
, where f(y˜
(t)
i |Φi) =
∏S−1
s=1 φ
(
log(yi,k+s)−µi,k+s
σi,k+s
)
× φ
(
log(y˜i,k+S)−µi,k+S
σi,k+S
)
, where
φ(·) is the pdf of the standard normal distribution. On rare occasions where yrepi,k+s < 4, the
imputed values were truncated to be 4; similarly yrepi,k+s > 365 was truncated to 365.
When subjects’ segment lengths are censored, we need to impute an FMP since it is
unobserved. We model the age at FMP Qi as a piecewise exponential distribution with
hazard hi(t) = ηk for Ak−1 ≤ t < Ak for knots k = 1, ..., K. Knots are set at age 40, 42, 43, 44,
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45, 46, 46.5, 47, 47.5, 48, 48.5, 49, 49.5, 50, 50.5, 51, 51.5, 52, 52.5, 53, 53.5, 54, 55, 56, 57, and
60. We first obtain a draw from p(ηk | Q) ∼ GAMMA(
∑
i I(Ak−1 ≤ Qi ≤ Ak),
∑
i I(Qi ≥
Ak−1)) for k = 1, . . . , K, where Q includes both the observed FMP and those imputed at the
previous iteration of Gibbs sampler. As in the intermittent missing setting, we then obtain a
draw log(yrep
i,T repi +1
) ∼ N(µi,T repi , σ2i,T repi ) where µi,T repi = α
µ
i +β
µ
i (ai,T repi −35)++γ
µ
i (ai,T repi −θ
µ
i )+
and σ2
i,T repi
= exp(ασi +β
σ
i (ai,T repi −35)++γσi (ai,T repi − θσi )+), ai,T repi = aiT repi +yiT repi is the age
of the start of segment yrep
i,T repi
, and T repi is the number of observed segments plus the number
of imputed segements in any intermittent missing gaps. We then obtain a draw Wi,1 from a
Bernoulli distribution with probability
P (ai,T repi ≤ Qi ≤ ai,T repi +1 | Qi > max(ai,T repi , θ
µ
i , θ
σ
i ))
=

0 if ai,T repi ≤ max(θ
µ
i , θ
σ
i )
1− e−ηk(ai,Trepi +1−ai,Trepi ) if ai,T repi > max(θ
µ
i , θ
σ
i ),
ai,T repi , ai,T
rep
i +1
∈ [Ak−1, Ak]
1− e−
»
ηk(ai,Trep
i
+1
−Ak−1)−ηk−1(ai,Trep
i
−Ak−1)
–
if ai,T repi > max(θ
µ
i , θ
σ
i ), ai,T repi ∈ [Ak−2, Ak−1],
ai,T repi +1 ∈ [Ak−1, Ak]
1− e−
»
ηk+1(ai,Trep
i
+1
−Ak)+ηk(Ak−Ak−1)−ηk−1(ai,Trep
i
−Ak−1)
–
if ai,T repi > max(θ
µ
i , θ
σ
i ), ai,T repi ∈ [Ak−2, Ak−1],
ai,T repi +1 ∈ [Ak, Ak+1]
Note that the FMP must occur after both the last observed segment and the latent mean
and variance changepoints; also, since none of our knots are less than six months apart, a
segment can cover a maximum of 3 intervals. If Wi,1 = 1, y
rep
i,T repi +1
is the length of the final
FMP. If Wi,1 = 0, we draw log(y
rep
i,T repi +2
) ∼ N(µi,T repi +1, σ2i,T repi +1) and repeat the process s
times until one of the following occurs: Wi,T repi +s = 1, y
rep
i,T repi +1
> 365 or arep
i,T repi +s
≥ 60. For
the vast majority of subjects, the FMP variable trigged the end of the imputation. For more
details, see Appendix B.
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4 Results
We use the methodology described in section 3 to analyze TREMIN data using MATLAB
software. We ran two MCMC chains for 10,000 iterations each after discarding the first
10,000 draws as “burn-in”. We assessed convergence using the Gelman and Rubin statistic
(Gelman et al. 2004), with a thinning interval of 5 segments. All of the population and
98% of the individual-level parameters had a value of less than 1.2, indicating reasonable
convergence.
4.1 Individual Level Parameters
To visually assess model fit at the individual level, Figure 2 plots the observed segment
lengths and predicted means and variances for the same four sampled women described in
Figure 1. The model appears to capture the trajectories well, with approximately 5% of
cycle lengths excluded from the 95% predictive intervals. The uncertainty in the position of
the variance changepoint is highlighted in (b) and (c).
Figure 3 plots the posterior means and 90% credible intervals of the mean and vari-
ance changepoints for 50 randomly selected women. As noted by Treloar et al. (1981) and
Lisabeth et al. (2004b), variability generally begin to increase before mean length. Sub-
jects with earlier changepoints averaged 4-5 years between mean and variance changepoints,
whereas subjects with later changepoints averaged only 1-2 years between mean and vari-
ance changepoints, consistent with the findings of Harlow et al. (2008). Uncertainty in the
variance changepoints is generally greater than in the mean changepoints.
Figure 4 plots the posterior medians of the mean and variance changepoints against the
final menstural periods (FMPs) for the 304 women with observed FMPs. FMPs occured on
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average 3.6 years after the mean changepoint, with a standard deviation of 1.4 years. FMPs
occured on average 6.5 years after the variance changepoint, with a standard deviation of
2.5 years. The mean time to FMP after the mean changepoint was fairly constant with
respect to age at mean changepoint; mean time to FMP after the variance changepoint was
considerably shorter in women with later variance changepoints than in younger women.
4.2 Population Level Parameters
Table 1 summarizes the posterior means and associated 95% credible intervals for the popu-
lation level segment length mean and variance regression parameters. The population mean
age at the changepoint for segment length means is 46.20 years (95% CI 45.87-46.54 years),
older than the population mean age at changepoints for segment length variability, which
is 42.21 years (95% CI 41.84-42.58 years); thus variability in segment length is predicted
to begin increasing 3.24 years earlier (95% CI 2.97-3.51 years) in the population than the
mean segment length itself. Mean segment length declined about 1% per year before the
changepoint and increased about 15% per year afterwards. Variability of log-segment length
was stable before the changepoint and increased by 79% per year after the changepoint.
Table 2 presents the posterior mean and associated 95% posterior predictive interval for
the correlation matrix corresponding to the covariance matrix Ω. The 95% credible intervals
of correlations that exclude zeros are denoted in bold.
• Later changepoints for variance are highly associated with later changepoints for mean.
• Later changepoints for both mean and variance are also correlated with longer and
more variable segment lengths, and more rapid increases in mean and variance after the
changepoint; consequently mean and variance slopes after changepoints are positively
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correlated.
• Greater mean length is associated with greater declines in variability before the variance
changepoint and greater increases in variability after.
• Larger segment variability is associated with longer mean segment length.
• Larger segment variability is highly associated with more rapid declines in variability
before but larger increases in variability after the variance changepoint: thus change
in variability before and after the variance changepoint is negatively correlated.
We conducted a principal components analysis of Ω to determine if the relationships
among the eight parameters governing perimenopause segment lengths could be summarized
in a smaller number of dimensions. Table 3 shows that four components explained 82% of the
variance of the individual level parameters governing menstrual segment length. The first
component loads heavily on the inverse relationship between the slope of the variances before
and after the variance changepoint, and on late mean and variance changepoints. The second
component also loads on the inverse relationship between the slope of the variances before
and after the variance changepoint, but picks up a relationship between early changepoints in
means and variances and smaller increases in means after the mean changepoint. The third
and fourth components load on the relationship between the mean intercepts and slopes:
the third component relates longer mean segment lengths at age 35 with more rapid declines
in mean length before the mean changepoint and less rapid increases thereafter, while the
fourth component relates shorter mean segment lengths at age 35 with more rapid declines
in mean length before the mean changepoint and more rapid increases thereafter.
We also fit a two-covariate model, including parity and age at menarche. As covariates
showed no significant relationships with the eight parameters describing the menopausal
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transition, we do not show the results here.
4.3 Posterior Predictive Model Check
We used posterior predictive distribution checks (Gelman et al. 1996) to assess model fit. We
calculated the χ2 discrepancy statistic for observed segment lengths of each individual woman
given by
∑
t
(yit−µrepit )2
(σrepit )
2 , which will have a χ
2
T obsi
distribution if the model is correct, where
T obsi is the total number of observed segments for the i
th woman. We assessed corresponding
predictive p-values for these χ2 test statistics based on 250 replications. Figure 5 shows the
predictive p-values for all subjects. No subjects had a posterior predictive p-values greater
than 0.95 and only one subject has a posterior predictive p-value smaller than 0.05. Review
of subjects with low posterior predictive p-values show that they contain one or two sporadic
very short or very long segments well before the onset of the increase in variability, suggesting
that these subjects contain outlying segment lengths rather than indicating more general
model failure. Subjects with high posterior predictive p-values generally had relatively few
observations with little variability – the variance estimates were smoothed back toward larger
values, yielding small χ2 discrepancy statistics.
To consider the appropriateness of the final menstrual period modeling, we plot the
observed and predicted FMPs together with the censoring ages for 100 randomly selected
women in Figure 6. The method for estimating FMP when not observed appears to have
worked well, with the distribution for the predicted FMPs corresponding closely to the
observed FMPs when the censoring age is relatively early and little information is usually
available to predict FMP.
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5 Discussion
In this article we have provided a Bayesian changepoint model for describing the patterns of
means and variances of women’s menstrual segment lengths as they approach menopause.
Our model detects individual changepoints of mean and variance of segment lengths for
each individual woman. The model is applied to the TREMIN data. Multiple imputations
integrated with an MCMC chain are carried out to impute the different kinds of missingness
in the data set. Instead of setting splines at a certain fixed point for all women and using
traditional random effect models to study menstrual patterns (Harlow et al. 2000), our
model allows the changepoints to be unknown parameters that vary for different subjects.
This setting provides a flexible way of capturing both the mean and variability of each
individual’s segment length trajectory.
Our work develops a data-driven definition of early and late transition defined by subject-
level variance and mean changepoints respectively. We observed a 3.2 year difference in age
between mean and variance changepoints at the population level, somewhat shorter than that
of Lisabeth et al. (2004b), who reported a 3.9 year difference between cycle lengths with
standard deviations of 6 days and the first cycle of 60 days or more. In addition, our results
were consistent with those of Wallace et al. (1979), Den Tonkelaar et al. (1998), and Lisabeth
et al. (2004b), who found that longer mean segment lengths were associated with later FMPs.
Our results were also consistent with those of Weinstein et al. (2003), who found that lower
variability was associated with early FMPs. We further found relationships between rates
of change in length and variability before and after changepoints themselves, in particular
that greater baseline variability was associated with more rapid declines in variability before
variance changepoints and greater increases thereafter; and later mean changepoints were
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associated with greater increases in mean length and more mean variability after mean
changepoints. These data contribute to efforts to define a staging system for reproductive
aging as they further our understanding of the timing and duration of the menopausal
transition and describe the nature of heterogeneity in women’s experience.
Our next step is to add the second TREMIN cohort data to assess changes of women’s
menstrual pattern in different generations by adding secular cohort (1935-1970 vs. 1960-
1995) as a population-level covariate to the model. Also, while model checking showed
that the model provides an adequate fit to the data, the model might still be improved.
Distributions of individual level variance parameters (not shown) are somewhat skewed or
heavy-tailed, suggesting a mixture distribution might be more suitable than one normal
distribution for all subjects. Thus, a latent class model with subjects belonging to one of
several underlying categories might fit the data even better. Estimation in the presence of
left censoring is also of interest as many recent and ongoing studies enrolled prevalent cohorts
including women who had already begun the menopausal transition.
Carroll (2003), in a paper entitled “Variances are not Always Nuisance Parameters,”
called for increased focus on developing methods for “variance structures” in order to better
understand how “systematic dependence of variability on known factors” could yield both
better prediction and improved inference. We agree with Carroll that incorporating infor-
mation from subject-level variability in longitudinal data settings is underutilized in clinical
and epidemiological research settings, at least in part because of the lack of methods for such
analyses. In our application, it would be of interest to identify sub-groups of women who
experience distinct patterns of variability during the menopausal transition and evaluate
whether these subgroups also differ in their risk for developing chronic disease. We believe
the analysis provided here begins to fill in some of the gaps in this area.
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APPENDIX
A Gibbs Sampling Algorithm
Gibbs sampling is used to draw from the posterior distribution p(Φ,Λ,Ω|z), where Φi =
(αµi , β
µ
i , γ
µ
i , θ
µ
i , α
σ
i , β
σ
i , γ
σ
i , θ
σ
i )
′. The algorithm outline is as follows:
1. Initialize Φ,Λ,Ω. Perform an initial imputation of missing data.
2. For i = 1, ..., n and zi consisting of both observed and imputed data:
2a.
(αµi , β
µ
i , γ
µ
i |rest) ∼ N((Aµ
′
i W
−1
i A
µ
i + Ω
−1
µ )
−1(Aµ
′
i W
−1
i zi + Ω
−1
µ x
′
iΛµ), (A
µ′
i W
−1
i A
µ
i + Ω
−1
µ )
−1)
where Wi = Diag(σ
2
it), A
µ
i =

1 (ai1 − 35) (ai1 − θµi )+
...
...
...
1 (aiTi − 35) (aiTi − θµi )+
, and Λµ and Ωµ are the
corresponding part of prior multivariate normal mean Λ and covariance matrix Ω conditional
on other parameters.
2b.
p(ασi |rest) ∝ exp(−
ασi Ti
2
)× exp(−1
2
(
Ti∑
t=1
zit − (αµi + βµi (ait − 35) + γµi (ait − θµi )+)2
exp(ασi + β
σ
i (ait − 35) + γσi (ait − θσi )+)
+
(ασi − µασ)2
Ωασ
))
where µασ = x
′
iΛασ and Ωασ are the corresponding part of prior multivariate normal mean
and variance conditional on other parameters. The inverse CDF method is used to obtain
the conditional draws.
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2c.
p(βσi |rest) ∝ exp(−
1
2
βσi
Ti∑
t=1
(ait − 35))× exp(−1
2
(
Ti∑
t=1
zit − (αµi + βµi (ait − 35) + γµi (ait − θµi )+)2
exp(ασi + β
σ
i (ait − 35) + γσi (ait − θσi )+)
+
(βσi − µβσ)2
Ωβσ
))
where µβσ = x
′
iΛβσ and Ωβσ are the corresponding part of prior multivariate normal mean
and variance conditional on other parameters. The inverse CDF method is used to obtain
the conditional draws.
2d.
p(γσi |rest) ∝ exp(−
1
2
γσi
Ti∑
t=1
(ait − θσi )+)× exp(−
1
2
(
Ti∑
t=1
zit − (αµi + βµi (ait − 35) + γµi (ait − θµi )+)2
exp(ασi + β
σ
i (ait − 35) + γσi (ait − θσi )+)
+
(γσi − µγσ)2
Ωγσ
))
where µγσ = x
′
iΛγσ and Ωγσ are the corresponding part of prior multivariate normal mean
and variance conditional on other parameters. The inverse CDF method is used to obtain
the conditional draws.
2e.
p(θµi |rest) ∝ exp(−
1
2
(
Ti∑
t=1
zit − (αµi + βµi (ait − 35) + γµi (ait − θµi )+)2
exp(ασi + β
σ
i (ait − 35) + γσi (ait − θσi )+)
+
(θµi − µθµ)2
Ωθµ
))
where µθµ = x
′
iΛθµ and Ωθµ are the corresponding part of prior multivariate normal mean
and variance conditional on other parameters. The inverse CDF method is used to obtain
the conditional draws.
2f.
p(θσi |rest) ∝ exp(−
1
2
γσi
Ti∑
t=1
(ait − θσi )+)× exp(−
1
2
(
Ti∑
t=1
zit − (αµi + βµi (ait − 35) + γµi (ait − θµi )+)2
exp(ασi + β
σ
i (ait − 35) + γσi (ait − θσi )+)
+
(θσi − µθσ)2
Ωθσ
))
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where µθσ = x
′
iΛθσ and Ωθσ are the corresponding part of prior multivariate normal mean
and variance conditional on other parameters. The inverse CDF method is used to obtain
the conditional draws.
3.
Λ|rest ∼ N((X ′(Ω⊗ IN)−1X)−1X ′(Ω⊗ IN)−1Φ, (X ′(Ω⊗ IN)−1X)−1)
where X is the covariate matrix of all subjects, which consists of stacked rows of x′i, and Φ
consists of the stacked rows of Φ′i.
4.
Ω|rest ∼ Inv −Wishart(Ω|(
N∑
i=1
(Φi − x′iΛ)(Φi − x′iΛ)′ + I))
5. Use the updated parameters to create a new imputation data set. Then go to step 2.
B Piecewise Exponential Distribution
Assume that Qi, the age at FMP, follows a piecewise exponential distribution. The baseline
hazard is constant within each interval, so that
λ0(t) = ηk, t ∈ [Ak−1, Ak]
f(Qi = t : t ∈ [Ak−1, Ak]) = ηke−ηkt
Here, A0, ...AK are a set of age knots, which are set at age 40, 42, 43, 44, 45, 46, 46.5, 47,
47.5, 48, 48.5, 49, 49.5, 50, 51.5, 52, 52.5, 53, 53.5, 54, 55, 56, and 57; we define A−1 = 0
and AK+1 =∞ and assume η0 = 0 (no risk of FMP before age 40).
We postulate a very weakly informative prior for ηk : ηk ∼ Gamma(0.001, 0.001). The
posterior distribution for ηk is:
p(ηk|q˜) ∝ p(q˜|ηk)p(ηk) ∝ Gamma(mk + 0.001, rk + 0.001)
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where mk =
∑
i I(Ak−1 ≤ Qi ≤ Ak) is the number of women with FMPs that occur between
time Ak−1 and Ak and rk =
∑
i I(Qi ≥ Ak−1) is the number of women without an FMP at
time Ak−1.
Since we have no covariates, the hazard function for each interval is
λ(t) = ηkI(Ak−1 ≤ t ≤ Ak)
The cumulative hazard and survival functions are then given by
Λ(t) =
∫ t
0
λ(t)dt =
k−1∑
j=1
ηj(Aj − Aj−1) + ηk(t− Ak−1), t ∈ [Ak−1, Ak]
S(t) = exp(−Λ(t))
The probability that the event occurs in the interval [t1, t2] given that the event has not
occured by t1 is
P (Qi ∈ [t1, t2]|Qi > t1) = S(t1)− S(t2)
S(t1)
= 1− S(t2)
S(t1)
=

1− e−ηk(t2−t1) if Ak−1 ≤ t1 < t2 ≤ Ak
1− e−[ηk(t2−Ak−1)−ηk−1(t1−Ak−1)] if Ak−2 ≤ t1 < Ak−1 ≤ t2 ≤ Ak
1− e−[ηk+1(t2−Ak)+ηk(Ak−Ak−1)−ηk−1(t1−Ak−1)] if Ak−2 ≤ t1 < Ak−1 < Ak ≤ t2
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Parameter Λ (95%CI)
Mean intercept 3.313(3.306,3.321)
Mean slope before changepoint -0.007(-0.010,-0.003)
Mean slope after changepoint 0.139(0.124,0.155)
Segment length mean changepoint 45.95(45.66,46.24)
Log-variance intercept -4.814(-4.927,-4.704)
Log-variance slope before changepoint 0.016(-0.015,0.047)
Log-variance slope after changepoint 0.583(0.528,0.636)
Segment length variance changepoint 42.71(42.38,43.03)
Table 1: Posterior mean of population level regression coefficients (Λ) estimates and associ-
ated 95% posterior predictive intervals.
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Loadings
PC1 PC2 PC3 PC4
Mean intercept 0.22 -0.14 0.63 -0.32
Mean slope before changepoint -0.03 0.00 -0.61 -0.75
Mean slope after changepoint 0.24 -0.19 -0.44 0.55
Mean changepoint 0.45 -0.40 -0.01 -0.10
Log-variance intercept 0.36 0.45 0.09 -0.06
Log-variance slope before changepoint -0.42 -0.50 0.02 0.03
Log-variance slope after changepoint 0.51 0.16 -0.15 0.06
Log-variance changepoint 0.36 -0.55 0.00 -0.10
Cumulative percent variance explained 35.3 56.1 69.9 81.9
Table 3: Principal components analysis of menstrual segment length parameters.
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Figure 1: Four sampled women’s log-segment-length trajectory after age 35: subject (a) has
no missing data, the green gap is due to pregnancy and no imputation is needed. The black
dot at the end means that FMP was observed for this subject. Subject (b) used hormones
for a period of time, the red gap is due to hormone use. FMP is observed for this subject.
Subject (c) has two pregnancy gaps (green gaps) and intermittent missingness at around
age 36 (black circle). The red dot at the end represent that the subject’s menstruation
was truncated by surgery. Subject (d) has a pregnancy gap (green gap), an intermittent
missingness (black circle) and a loss of contact gap (black gap). Her menstruation was
censored due to hormone use (red line) and missing afterwards.
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Figure 2: Data from four women: Red lines represent posterior mean of the mean segment
length and associated 95% credible intervals; green lines represent posterior mean for the
upper and lower 2.5 percentiles for the segment distribution and their associated 95% credible
intervals. Black dots represent log of observed segment lengths.
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Figure 3: Posterior means and 90% posterior predictive intervals for mean changepoints and
variance changepoints (100 randomly selected women).
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Figure 4: Posterior means of mean and variance changepoints versus final menstrual period
for 304 women with observed final menstrual periods.
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Figure 5: Histogram of p-values of subject level posterior predictive χ2 tests.
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Figure 6: Observed FMP (circle) and posterior medians (squares) and 95% predictive interval
for unobserved FMPs. X indicates age at censoring. (100 randomly selected women.)
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